 | • レポートコード：MRC2102QY1499 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のアキシチニブ市場について種類別（注射、その他）、用途別（腎がん治療、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・アキシチニブ市場の概要 ・世界の主要地域別アキシチニブ市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のアキシチニブ市場規模2015-2026：種類別（注射、その他） ・世界のアキシチニブ市場規模2015-2026：用途別（腎がん治療、その他） ・アキシチニブの米国市場規模2015-2020 ・アキシチニブのヨーロッパ市場規模2015-2020 ・アキシチニブの中国市場規模2015-2020 ・アキシチニブの日本市場規模2015-2020 ・アキシチニブの東南アジア市場規模2015-2020 ・アキシチニブのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・アキシチニブの製造コスト分析 ・販売チャネル、流通業者、顧客 ・アキシチニブの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Axitinib Market
The global Axitinib market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Axitinib Scope and Market Size
The global Axitinib market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Axitinib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Axitinib market is segmented into
Injection
Others
Segment by Application, the Axitinib market is segmented into
Renal Cancer Treatment
Others
The Axitinib market is analysed and market size information is provided by regions (countries). Segment by Application, the Axitinib market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Axitinib Market Share Analysis
Axitinib market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Axitinib business, the date to enter into the Axitinib market, Axitinib product introduction, recent developments, etc.
The major vendors covered:
Pfizer
1 Axitinib Market Overview
1.1 Axitinib Product Scope
1.2 Axitinib Segment by Type
1.2.1 Global Axitinib Sales by Type (2020-2026)
1.2.2 Injection
1.2.3 Others
1.3 Axitinib Segment by Application
1.3.1 Global Axitinib Sales Comparison by Application (2020-2026)
1.3.2 Renal Cancer Treatment
1.3.3 Others
1.4 Axitinib Market Estimates and Forecasts (2015-2026)
1.4.1 Global Axitinib Sales Growth Rate (2015-2026)
1.4.2 Global Axitinib Revenue and Growth Rate (2015-2026)
1.4.3 Global Axitinib Price Trends (2015-2026)
2 Axitinib Estimate and Forecast by Region
2.1 Global Axitinib Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Axitinib Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Axitinib Sales Market Share by Region (2015-2020)
2.2.2 Global Axitinib Revenue Market Share by Region (2015-2020)
2.3 Global Axitinib Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Axitinib Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Axitinib Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Axitinib Estimates and Projections (2015-2026)
2.4.2 Europe Axitinib Estimates and Projections (2015-2026)
2.4.3 China Axitinib Estimates and Projections (2015-2026)
2.4.4 Japan Axitinib Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Axitinib Estimates and Projections (2015-2026)
2.4.6 India Axitinib Estimates and Projections (2015-2026)
3 Global Axitinib Competition Landscape by Players
3.1 Global Top Axitinib Players by Sales (2015-2020)
3.2 Global Top Axitinib Players by Revenue (2015-2020)
3.3 Global Axitinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Axitinib as of 2019)
3.4 Global Axitinib Average Price by Company (2015-2020)
3.5 Manufacturers Axitinib Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Axitinib Players (Opinion Leaders)
4 Global Axitinib Market Size by Type
4.1 Global Axitinib Historic Market Review by Type (2015-2020)
4.1.1 Global Axitinib Sales Market Share by Type (2015-2020)
4.1.2 Global Axitinib Revenue Market Share by Type (2015-2020)
4.1.3 Global Axitinib Price by Type (2015-2020)
4.2 Global Axitinib Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Axitinib Sales Forecast by Type (2021-2026)
4.2.2 Global Axitinib Revenue Forecast by Type (2021-2026)
4.2.3 Global Axitinib Price Forecast by Type (2021-2026)
5 Global Axitinib Market Size by Application
5.1 Global Axitinib Historic Market Review by Application (2015-2020)
5.1.1 Global Axitinib Sales Market Share by Application (2015-2020)
5.1.2 Global Axitinib Revenue Market Share by Application (2015-2020)
5.1.3 Global Axitinib Price by Application (2015-2020)
5.2 Global Axitinib Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Axitinib Sales Forecast by Application (2021-2026)
5.2.2 Global Axitinib Revenue Forecast by Application (2021-2026)
5.2.3 Global Axitinib Price Forecast by Application (2021-2026)
6 United States Axitinib Market Facts & Figures
6.1 United States Axitinib Sales Market Share by Company (2015-2020)
6.2 United States Axitinib Sales Market Share by Type (2015-2020)
6.3 United States Axitinib Sales Market Share by Application (2015-2020)
7 Europe Axitinib Market Facts & Figures
7.1 Europe Axitinib Sales Market Share by Company (2015-2020)
7.2 Europe Axitinib Sales Market Share by Type (2015-2020)
7.3 Europe Axitinib Sales Market Share by Application (2015-2020)
8 China Axitinib Market Facts & Figures
8.1 China Axitinib Sales Market Share by Company (2015-2020)
8.2 China Axitinib Sales Market Share by Type (2015-2020)
8.3 China Axitinib Sales Market Share by Application (2015-2020)
9 Japan Axitinib Market Facts & Figures
9.1 Japan Axitinib Sales Market Share by Company (3015-3030)
9.2 Japan Axitinib Sales Market Share by Type (2015-2020)
9.3 Japan Axitinib Sales Market Share by Application (2015-2020)
10 Southeast Asia Axitinib Market Facts & Figures
10.1 Southeast Asia Axitinib Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Axitinib Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Axitinib Sales Market Share by Application (2015-2020)
11 India Axitinib Market Facts & Figures
11.1 India Axitinib Sales Market Share by Company (2015-2020)
11.2 India Axitinib Sales Market Share by Type (2015-2020)
11.3 India Axitinib Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Axitinib Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Axitinib Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Axitinib Products Offered
12.1.5 Pfizer Recent Development
…
13 Axitinib Manufacturing Cost Analysis
13.1 Axitinib Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Axitinib
13.4 Axitinib Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Axitinib Distributors List
14.3 Axitinib Customers
15 Market Dynamics
15.1 Axitinib Market Trends
15.2 Axitinib Opportunities and Drivers
15.3 Axitinib Market Challenges
15.4 Axitinib Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Axitinib Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Axitinib Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Axitinib Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Axitinib Sales (MT) by Region (2015-2020)
Table 5. Global Axitinib Sales Market Share by Region (2015-2020)
Table 6. Global Axitinib Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Axitinib Revenue Share by Region (2015-2020)
Table 8. Global Axitinib Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Axitinib Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Axitinib Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Axitinib Revenue Share Forecast by Region (2021-2026)
Table 12. Global Axitinib (MT) of Key Companies (2015-2020)
Table 13. Global Axitinib Sales Share by Company (2015-2020)
Table 14. Global Axitinib Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Axitinib Revenue Share by Company (2015-2020)
Table 16. Global Axitinib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Axitinib as of 2019)
Table 17. Global Axitinib Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Axitinib Manufacturing Sites and Area Served
Table 19. Manufacturers Axitinib Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Axitinib Players
Table 22. Global Axitinib Sales (MT) by Type (2015-2020)
Table 23. Global Axitinib Sales Share by Type (2015-2020)
Table 24. Global Axitinib Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Axitinib Price (MT) by Type (2015-2020)
Table 26. Global Axitinib Sales Share by Type (2021-2026)
Table 27. Global Axitinib Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Axitinib Revenue Share by Type (2021-2026)
Table 29. Global Axitinib Price (MT) by Type (2021-2026)
Table 30. Global Axitinib Sales (MT) by Application (2015-2020)
Table 31. Global Axitinib Sales Share by Application (2015-2020)
Table 32. Global Axitinib Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Axitinib Price (MT) by Application (2015-2020)
Table 34. Global Axitinib Sales (MT) by Application (2021-2026)
Table 35. Global Axitinib Sales Share by Application (2021-2026)
Table 36. Global Axitinib Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Axitinib Revenue Share by Application (2021-2026)
Table 38. Global Axitinib Price (MT) by Application (2021-2026)
Table 39. United States Axitinib Sales (MT) by Company (2015-2020)
Table 40. United States Axitinib Sales Market Share by Company (2015-2020)
Table 41. United States Axitinib Sales (MT) by Type (2015-2020)
Table 42. United States Axitinib Sales Market Share by Type (2015-2020)
Table 43. United States Axitinib Sales (MT) by Application (2015-2020)
Table 44. United States Axitinib Sales Market Share by Application (2015-2020)
Table 45. Europe Axitinib Sales (MT) by Company (2015-2020)
Table 46. Europe Axitinib Sales Market Share by Company (2015-2020)
Table 47. Europe Axitinib Sales (MT) by Type (2015-2020)
Table 48. Europe Axitinib Sales Market Share by Type (2015-2020)
Table 49. Europe Axitinib Sales (MT) by Application (2015-2020)
Table 50. Europe Axitinib Sales Market Share by Type (2015-2020)
Table 51. China Axitinib Sales (MT) by Company (2015-2020)
Table 52. China Axitinib Sales Market Share by Company (2015-2020)
Table 53. China Axitinib Sales (MT) by Type (2015-2020)
Table 54. China Axitinib Sales Market Share by Type (2015-2020)
Table 55. China Axitinib Sales (MT) by Application (2015-2020)
Table 56. China Axitinib Sales Market Share by Application (2015-2020)
Table 57. Japan Axitinib Sales (MT) by Company (2015-2020)
Table 58. Japan Axitinib Sales Market Share by Company (2015-2020)
Table 59. Japan Axitinib Sales (MT) by Type (2015-2020)
Table 60. Japan Axitinib Sales Market Share by Type (2015-2020)
Table 61. Japan Axitinib Sales (MT) by Application (2015-2020)
Table 62. Japan Axitinib Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Axitinib Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Axitinib Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Axitinib Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Axitinib Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Axitinib Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Axitinib Sales Market Share by Application (2015-2020)
Table 69. India Axitinib Sales (MT) by Company (2015-2020)
Table 70. India Axitinib Sales Market Share by Company (2015-2020)
Table 71. India Axitinib Sales (MT) by Type (2015-2020)
Table 72. India Axitinib Sales Market Share by Type (2015-2020)
Table 73. India Axitinib Sales (MT) by Application (2015-2020)
Table 74. India Axitinib Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Axitinib Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Pfizer Axitinib Product
Table 79. Pfizer Recent Development
Table 80. Production Base and Market Concentration Rate of Raw Material
Table 81. Key Suppliers of Raw Materials
Table 82. Axitinib Distributors List
Table 83. Axitinib Customers List
Table 84. Axitinib Market Key Trends
Table 85. Axitinib Key Opportunities and Drivers
Table 86. Axitinib Market Challenges
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Axitinib Product Picture
Figure 2. Global Axitinib Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Axitinib Market Share by Application in 2020 & 2026
Figure 6. Renal Cancer Treatment Examples
Figure 7. Others Examples
Figure 8. Global Axitinib Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Axitinib Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Axitinib Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Axitinib Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Axitinib Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Axitinib Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Axitinib Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Axitinib Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Axitinib Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Axitinib Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Axitinib Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Axitinib Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Axitinib Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Axitinib Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Axitinib Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Axitinib Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Axitinib Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Axitinib Players Market Share by Revenue in Axitinib 2015 & 2019
Figure 26. Axitinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Axitinib Revenue Share by Type (2015-2020)
Figure 28. Global Axitinib Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Axitinib Revenue Share by Application (2015-2020)
Figure 30. Global Axitinib Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Axitinib Sales Market Share by Type in 2019
Figure 32. United States Axitinib Sales Market Share by Type in 2019
Figure 33. Europe Axitinib Sales Market Share by Company in 2019
Figure 34. Europe Axitinib Sales Market Share by Type in 2019
Figure 35. Europe Axitinib Sales Market Share by Application in 2019
Figure 36. China Axitinib Sales Market Share by Company in 2019
Figure 37. China Axitinib Sales Market Share by Type in 2019
Figure 38. China Axitinib Sales Market Share by Application in 2019
Figure 39. Japan Axitinib Sales Market Share by Company in 2019
Figure 40. Japan Axitinib Sales Market Share by Type in 2019
Figure 41. Japan Axitinib Sales Market Share by Application in 2019
Figure 42. Southeast Asia Axitinib Sales Market Share by Company in 2019
Figure 43. Southeast Asia Axitinib Sales Market Share by Type in 2019
Figure 44. Southeast Asia Axitinib Sales Market Share by Application in 2019
Figure 45. India Axitinib Sales Market Share by Company in 2019
Figure 46. India Axitinib Sales Market Share by Type in 2019
Figure 47. India Axitinib Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Axitinib
Figure 50. Manufacturing Process Analysis of Axitinib
Figure 51. Axitinib Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
泌尿器がん治療薬の世界市場レポート2020 Global Urological Cancer Therapeutics Drugs Market is estimated to reach $48.6 billion by 2025 Says, .Now a days urological cancers became very common worldwide and causing higher mortality rates. Specially in the case of kidney cancers, that illustrates the new therapeutic targets. Urological cance…- 腎疾患治療装置の世界市場レポート2020 Renal Disease Treatment Devices are subdivided into urinary treatment, dialysis, pelvic organ prolapse treatment, endoscopic, benign prostatic hyperplasia treatment equipment, prostate stent, gravel, sacral nerve regulation, urethral insertion and pessary, urethral stent, vaginal network Sleeve and …
- 腎除神経カテーテルの世界市場レポート2020 The Paradise Renal Denervation System is a minimally invasive procedure to treat overactive nerves leading to the kidney. ... A small flexible catheter is inserted, and then placed in the artery supplying the kidney. Ultrasound energy (sound waves) is delivered to the tissue surrounding the artery f…
- 腎バイオマーカーの世界市場レポート2020 Market Analysis and Insights: Global Renal Biomarker Market The global Renal Biomarker market size is projected to reach US$ 1270.4 million by 2026, from US$ 1005.8 million in 2020, at a CAGR of 4.0% during 2021-2026. Global Renal Biomarker Scope and Market Size The global Renal Biomarker market is …
- がん治療用放射性ステントの世界市場レポート2020 Radioactive stent, the self-expanding stent with radioactivity particles is regards as very useful in the treatment of medium and advanced esophageal cancer. Jiangsu Province is the largest suppling place as the top 3 manufacturers are located therem Micro-Tech, Changzhou Zhiye and Changzhou Garson.…